and well down on its high of 15c, point being?The shareprice has...

and well down on its high of 15c, point being?

The shareprice has only recovered what it lost due to a panicked market. The performance in real terms of the stock has been poor in recent times although alot healthier than 8 months ago. I believe this is reflected by the lack of followup news.

As an example take the announcement of 4th of September about clinical trials beginning in the quarter. Almost 5 months on, no further comment about whether it did in fact start, how it is going or when it will finish. This is poor investor relations. They can do alot better.